Coronavirus disease (COVID-2019) R&D;
On 31 December 2019, WHO was informed of a cluster of cases of pneumonia of unknown cause detected in Wuhan City, Hubei Province of China. The coronavirus disease (COVID-2019) was identified as the causative virus by Chinese authorities on 7 January. As part of WHO’s response to the outbreak, the R&D; Blueprint has been activated to accelerate diagnostics, vaccines and therapeutics for this novel coronavirus.
COVID-19 Public Health Emergency of International Concern (PHEIC)
Global research and innovation forum: towards a research roadmap
On 30 January 2020, following the recommendations of the Emergency Committee, the WHO Director-General declared that the outbreak constitutes a Public Health Emergency of International Concern (PHEIC).
World scientists on COVID-19 met at the World Health Organization’s Geneva headquarters from 11 to 12 February 2020 to assess the current level of knowledge about the new virus, agree on critical research questions that need to be answered urgently, and ways to work together to accelerate and fund priority research that can contribute to curtail this outbreak and prepare for future outbreaks.
-
2019 Novel Coronavirus: Global Research and Innovation Forum: Towards a Research Roadmap/report
pdf, 431kb -
2019 Novel Coronavirus: Overview of the state of the art and outline of key knowledge gaps/slides
pdf, 3.89Mb
Latest reports
Vaccines
-
Draft landscape of COVID-19 candidate vaccines
pdf, 610kb
4 April 2020 -
COVID-19 Phase IIb/III Vaccine Trial Synopsis
pdf, 667kb
February 2020 -
Informal consultation on prioritization of candidate vaccines agents for use in novel coronavirus 2019 infection
pdf, 645kb
30 January 2020 -
Overview of the types/classes of candidate vaccines against MERS-CoV
pdf, 608kb -
Overview of the types/classes of candidate vaccines against SARS-CoV
pdf, 576kb -
WHO Consultation on Cross-Reactivity with other coronaviruses
pdf, 526kb
27 January 2020 -
WHO Consultation on Cross-Reactivity with other coronaviruses
24 January 2020 -
Outline of designs for experimental vaccines and therapeutics
pdf, 375kb
17 January 2020
Animal Models
-
WHO ad hoc COVID19 working group summary
pdf, 142kb
4 April 2020 -
WHO ad hoc COVID19 working group summary
pdf, 412kb
20 March 2020
Therapeutics
- Web base application to analyse clinical trials to evaluate therapeutics for COVID-19
-
Informal consultation on the role of prophylaxis and post-exposure prophylaxis
pdf, 565kb
Teleconference notes 31 March 2020 -
Informal consultation on the role of IL-6/IL-1.
pdf, 555kb
Teleconference notes 25 March 2020 -
Informal consultation on the role of therapeutics in COVID 19 prophylaxis and post-exposure prophylaxis
pdf, 635kb
18 March 2020 -
Informal consultation on the potential role of chloroquine in the clinical management of COVID 19 infection
pdf, 481kb
13 March 2020 -
COVID-19 Therapeutic Trial Synopsis
pdf, 895kb
18 February 2020 -
Outline of trial designs for experimental therapeutics
27 January 2020 -
Informal consultation on prioritization of candidate therapeutic agents for use in novel coronavirus 2019 infection
24 January 2020 -
Outline of designs for experimental vaccines and therapeutics
21 January 2020 -
Outline of designs for experimental vaccines and therapeutics
20 January 2020 -
Overview of the types/classes of candidate therapeutics
pdf, 921kb
Ethics
Diagnostics
Scientific Advisory Group
Global Coordination Mechanism
-
GCM teleconference on Pneumonia of unknown etiology in Wuhan, China – Note for the Records
pdf, 89kb
20 January 2020 -
GCM teleconference on Pneumonia of unknown etiology in Wuhan, China – Note for the Records
pdf, 333kb
10 January 2020